Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada-Reference-Cited by-同舟云学术

Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada

Author:

Minhas Rajwant¹^ORCID,Tadrous Mina²³⁴,Elterman Dean⁵⁶,Gomes Tara²³⁴⁷

Affiliation:

1. Faculty of Pharmaceutical Sciences; University of British Columbia; Vancouver British Columbia Canada

2. The Leslie Dan Faculty of Pharmacy; University of Toronto; Toronto Ontario Canada

3. Institute for Clinical Evaluative Sciences; Toronto Ontario Canada

4. Li Ka Shing Knowledge Institute; St. Michael's Hospital; Toronto Ontario Canada

5. Division of Urology; Department of Surgery; University Health Network; Toronto Ontario Canada

6. Department of Surgery; University of Toronto; Toronto Ontario Canada

7. Institute of Health Policy, Management, and Evaluation; University of Toronto; Toronto Ontario Canada

Funder

Canadian Institutes of Health Research

Ontario Ministry of Health and Long-Term Care

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Reference34 articles.

1. http://www.urologyhealth.org/overactive-bladder

2. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey;Herschorn;BJU Int,2008

4. Prevalence of overactive bladder and incontinence in Canada;Corcos;Can J Urol,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献